Clinical Trial Update: Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer [Phase 2, Phase 3]

View source ↗

Summary

This is an update on a completed Phase 2/Phase 3 trial evaluating preoperative chemotherapy with irinotecan (CPT-11) and cisplatin, combined with radiotherapy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Camptosar (irinotecan)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Esophageal Cancer | Phase 2, Phase 3 | Status: COMPLETED